StockData
BioNTech SE logo

BioNTech SE (BNTX) stock

BNTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 10, 2026Score 3/30
$83.26−1.60 (-1.89%)

Close on Nov 18, 2026Market cap $20.92BP/E –Yield –

BioNTech pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

BioNTech's pe ratio was 28.3× on Feb 28, 2025, against 2.2× a year earlier. Over the last 3 years it ranged from 2.2× to 31.1×, with a median of 3.6×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Feb 28, 202528.3×−0.4
2024Dec 31, 202428.7×+26.2
2023Dec 29, 20232.5×−1.0
2022Dec 30, 20223.5×–

More BioNTech figures

See a number that looks wrong?